Atria Wealth Solutions’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,308
Closed -$560K 1936
2023
Q3
$560K Sell
14,308
-4,263
-23% -$170K 0.01% 1080
2023
Q2
$755K Sell
18,571
-26,113
-58% -$1.07M 0.01% 974
2023
Q1
$1.87M Sell
44,684
-5,099
-10% -$215K 0.03% 567
2022
Q4
$2.17M Sell
49,783
-1,777
-3% -$75.5K 0.03% 485
2022
Q3
$2M Buy
+51,560
New +$2.2M 0.03% 480
2022
Q2
Sell
-12,740
Closed -$580K 1653
2022
Q1
$580K Buy
+12,740
New +$565K 0.01% 982

Other funds holding BME

Atria Wealth Solutions's BME Position: Q4 2023 in Review

Atria Wealth Solutions sold out of BlackRock Health Sciences Trust (BME) in Q4 2023, closing a stake of 14,308 shares — an estimated $560K sold.

Atria Wealth Solutions first reported a position in BME in Q1 2022 and held it in 6 quarters. The position peaked at $2.17M in Q4 2022. 73 funds tracked by Wall St. Rank hold BME as of Q4 2023.

  • Atria Wealth Solutions reported no remaining BlackRock Health Sciences Trust position as of Q4 2023 after selling out during the quarter.
  • Atria Wealth Solutions sold 14,308 BlackRock Health Sciences Trust shares in Q4 2023, an estimated $560K.
  • Atria Wealth Solutions first reported a position in BlackRock Health Sciences Trust in Q1 2022 and held it in 6 quarters.
  • Atria Wealth Solutions's BlackRock Health Sciences Trust position peaked at $2.17M in Q4 2022.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2023.

Based on Atria Wealth Solutions's 13F filing for Q4 2023, filed 2 Feb 2024.